The Emerging Translational Potential of MNK Inhibitors for the Treatment of Chronic Pain

Neuroscience. 2023 Apr 1:515:93-95. doi: 10.1016/j.neuroscience.2023.02.009.

Authors

Tyler S Nelson¹, Rajesh Khanna²

Affiliations

¹ Department of Molecular Pathobiology, College of Dentistry, New York University, 433 First Avenue, 8th Floor, New York, NY 10010, USA; NYU Pain Research Center, 433 First Avenue, New York, NY 10010, USA.
² Department of Molecular Pathobiology, College of Dentistry, New York University, 433 First Avenue, 8th Floor, New York, NY 10010, USA; NYU Pain Research Center, 433 First Avenue, New York, NY 10010, USA. Electronic address: [email protected].

No abstract available

Publication types

Editorial
Comment

MeSH terms

Chronic Pain* / drug therapy
Humans
Phosphorylation
Protein Processing, Post-Translational
Protein Serine-Threonine Kinases / metabolism

Substances

Protein Serine-Threonine Kinases

Grants and funding

K00 NS124190/NS/NINDS NIH HHS/United States